BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Srinivasan AR. Treat to target in Crohn’s disease: A practical guide for clinicians. World J Gastroenterol 2024; 30(1): 50-69 [PMID: 38293329 DOI: 10.3748/wjg.v30.i1.50]
URL: https://www.wjgnet.com/1007-9327/full/v30/i1/50.htm
Number Citing Articles
1
Justyna Lorenc-Góra, Dariusz Waniczek, Zenon P. Czuba, Mariusz Kryj, Zbigniew Lorenc, Małgorzata Muc-Wierzgoń. Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn’s DiseaseBiomolecules 2025; 15(1): 116 doi: 10.3390/biom15010116
2
Joana Mota, Maria João Almeida, Miguel Martins, Francisco Mendes, Pedro Cardoso, João Afonso, Tiago Ribeiro, João Ferreira, Filipa Fonseca, Manuel Limbert, Susana Lopes, Guilherme Macedo, Fernando Castro Poças, Miguel Mascarenhas. Artificial Intelligence in Coloproctology: A Review of Emerging Technologies and Clinical ApplicationsJournal of Clinical Medicine 2024; 13(19): 5842 doi: 10.3390/jcm13195842
3
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovationsWorld Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
4
Ashish Srinivasan, Daniel van Langenberg, Peter De Cruz, Jonathan Segal, Abhinav Vasudevan, Richard N. Upton. Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation StudyBioDrugs 2024; 38(5): 691 doi: 10.1007/s40259-024-00673-2
5
Sarah El-Nakeep. The intestinal ultrasound role in inflammatory bowel disease in clinical practice and a critical appraisal of the current guidelines (mini-review)The Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00316-6
6
Giulia Migliorisi, Elisabetta Mastrorocco, Arianna Dal Buono, Roberto Gabbiadini, Gaia Pellegatta, Paola Spaggiari, Francesca Racca, Enrico Heffler, Edoardo Vincenzo Savarino, Cristina Bezzio, Alessandro Repici, Alessandro Armuzzi. Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical ReviewJournal of Clinical Medicine 2024; 13(14): 4119 doi: 10.3390/jcm13144119
7
Fabrizio Fanizzi, Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese, Axel Dignass. Treatment targets in IBD: is it time for new strategies?Best Practice & Research Clinical Gastroenterology 2025; : 101990 doi: 10.1016/j.bpg.2025.101990
8
James D. Lewis, Aisha Vadhariya, Sylvia Su, Xian Zhou, Frederick Durand, Ariane K. Kawata, Larissa Stassek, Claudine Clucas, Stefan Schreiber. A patient-reported outcome measure comprising the stool frequency and abdominal pain items from the Crohn’s Disease Activity Index: psychometric evaluation in adults with Crohn’s diseaseJournal of Patient-Reported Outcomes 2025; 9(1) doi: 10.1186/s41687-025-00851-y
9
Hongsai Hu, Rong He, Minji Liu, Hongbing Zhou, Lin Tan, Qiongjia Ai, Qian Wang, Luwei Zeng, Weiming Qu. C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn’s DiseaseInternational Journal of General Medicine 2024; : 6219 doi: 10.2147/IJGM.S487505
10
Shintaro Nakao, Sentaro Kusuhara, Tomoaki Murakami. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphologyGraefe's Archive for Clinical and Experimental Ophthalmology 2024; 262(12): 3749 doi: 10.1007/s00417-024-06558-y
11
Joana Mota, Maria João Almeida, Francisco Mendes, Miguel Martins, Tiago Ribeiro, João Afonso, Pedro Cardoso, Helder Cardoso, Patricia Andrade, João Ferreira, Guilherme Macedo, Miguel Mascarenhas. A Comprehensive Review of Artificial Intelligence and Colon Capsule Endoscopy: Opportunities and ChallengesDiagnostics 2024; 14(18): 2072 doi: 10.3390/diagnostics14182072